{"id":"https://openalex.org/W2052216512","doi":"https://doi.org/10.1016/s0014-2999(97)01448-9","title":"Metalloproteinase inhibitor prevents hepatic injury in endotoxemic mice","display_name":"Metalloproteinase inhibitor prevents hepatic injury in endotoxemic mice","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W2052216512","doi":"https://doi.org/10.1016/s0014-2999(97)01448-9","mag":"2052216512","pmid":"https://pubmed.ncbi.nlm.nih.gov/9489862"},"language":"en","primary_location":{"id":"doi:10.1016/s0014-2999(97)01448-9","doi":"https://doi.org/10.1016/s0014-2999(97)01448-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-2999(97)01448-9","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079322951","display_name":"Kazuki Murakami","orcid":"https://orcid.org/0000-0002-0036-1151","observed_orcids":["https://orcid.org/0000-0002-0036-1151"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kazuki Murakami","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, Hirakata, Osaka, Japan. gcc39616@greencross.co.jp","Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, Hirakata, Osaka, Japan. gcc39616@greencross.co.jp","institution_ids":[]},{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032556796","display_name":"Fujio Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fujio Kobayashi","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003414522","display_name":"Ruriko Ikegawa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruriko Ikegawa","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109116425","display_name":"Mamoru Koyama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mamoru Koyama","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011411867","display_name":"Nahoko Shintani","orcid":"https://orcid.org/0009-0003-8709-7537","observed_orcids":["https://orcid.org/0009-0003-8709-7537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nahoko Shintani","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013659565","display_name":"Tomohiro Yoshida","orcid":"https://orcid.org/0000-0003-3096-011X","observed_orcids":["https://orcid.org/0000-0003-3096-011X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomohiro Yoshida","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102812948","display_name":"Norifumi Nakamura","orcid":"https://orcid.org/0000-0002-8919-6753","observed_orcids":["https://orcid.org/0000-0002-8919-6753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norifumi Nakamura","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113739142","display_name":"Takao Kondo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takao Kondo","raw_affiliation_strings":["Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Laboratories, Research Division, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5079322951"],"corresponding_institution_ids":[],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":2.5639,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.88496622,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"341","issue":"1","first_page":"105","last_page":"110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.7651000022888184,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.7651000022888184,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.09920000284910202,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.03970000147819519,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/matrix-metalloproteinase-inhibitors","display_name":"matrix metalloproteinase inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/endotoxemia","display_name":"endotoxemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/liver-injury","display_name":"liver injury","score":0.8790000081062317},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.781000018119812},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9160000085830688},{"id":"https://openalex.org/keywords/d-galactosamine","display_name":"D-galactosamine","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8920000195503235},{"id":"https://openalex.org/keywords/hepatocellular-necrosis","display_name":"liver necrosis","score":0.7860000133514404},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.8375909328460693},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.731783390045166},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.639725923538208},{"id":"https://openalex.org/C2781467277","wikidata":"https://www.wikidata.org/wiki/Q375145","display_name":"Galactosamine","level":3,"score":0.6089701652526855},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5445353388786316},{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.5010111331939697},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4693637192249298},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.46398165822029114},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.4621935486793518},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4537305533885956},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44761922955513},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.42125651240348816},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3897438645362854},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14037811756134033},{"id":"https://openalex.org/C2778125326","wikidata":"https://www.wikidata.org/wiki/Q327506","display_name":"Glucosamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000293","qualifier_name":"injuries","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008666","descriptor_name":"Metalloendopeptidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D010649","descriptor_name":"Phenylalanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D010649","descriptor_name":"Phenylalanine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014947","descriptor_name":"Wounds and Injuries","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014947","descriptor_name":"Wounds and Injuries","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014947","descriptor_name":"Wounds and Injuries","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D019446","descriptor_name":"Endotoxemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D019446","descriptor_name":"Endotoxemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D019446","descriptor_name":"Endotoxemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0014-2999(97)01448-9","doi":"https://doi.org/10.1016/s0014-2999(97)01448-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-2999(97)01448-9","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:9489862","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9489862","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W125060595","https://openalex.org/W1503094954","https://openalex.org/W1922003970","https://openalex.org/W1968713831","https://openalex.org/W1998491594","https://openalex.org/W1999246265","https://openalex.org/W2005111715","https://openalex.org/W2009550948","https://openalex.org/W2011291552","https://openalex.org/W2031873118","https://openalex.org/W2036842448","https://openalex.org/W2038434279","https://openalex.org/W2041233605","https://openalex.org/W2041466047","https://openalex.org/W2052445471","https://openalex.org/W2062784484","https://openalex.org/W2067534266","https://openalex.org/W2074881372","https://openalex.org/W2085486418","https://openalex.org/W2086255604","https://openalex.org/W2097409392","https://openalex.org/W2129889907","https://openalex.org/W2164802863","https://openalex.org/W2172408425","https://openalex.org/W2176899369","https://openalex.org/W2181666692","https://openalex.org/W2321427723","https://openalex.org/W2342956794"],"related_works":["https://openalex.org/W1922003970","https://openalex.org/W1985231739","https://openalex.org/W2121386098","https://openalex.org/W2116508163","https://openalex.org/W2003403133","https://openalex.org/W2082130191","https://openalex.org/W2151897497","https://openalex.org/W2026460899","https://openalex.org/W2073192795","https://openalex.org/W2112219505"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}